期刊文献+

中西药四联疗法治疗狼疮肾炎探索 被引量:1

Study of the Four Union Therapy of Chinese and Western Medicine For Lupus Nephritis
下载PDF
导出
摘要 目的观察中西药四联疗法治疗狼疮肾炎的效果。方法方案1为小剂量泼尼松+硫唑嘌呤+氨甲碟呤+补肾康,方案2为小剂量泼尼松+硫唑嘌呤+氨甲碟呤+火把花根,疗程3个月,观察半年到1年。结果7例采用方案1,显效4例(其中2例显著改善),无效3例;12例采用方案2,显效8例(其中5例显著改善),无效4例。结论该疗法法治疗狼疮肾炎有一定效果,以方案2较佳。 Objective To explore the efficiency of herbal plus Westen medicine therapy for lupus nephritis. Methods Two therapy projects were used to treat patients with lupus nephritis. Project 1 was low-dose prednisone plus azathioprine plus methotrexate plus Piperazine Ferulate. Project 2 was low-dose prednisone plus azathioprine plus methotrexate plus Tripterggium Wilfordii, The period of treatment was 3 months : the whole period of observing was 6 months or one year. The changes of clinic representation and experiment index were observed to compare the curative effect of two projects. Results 7 cases in project 1,4 cases were effect ( 2 marked efficacy) ,3 inefficacy; 12 in project 2,8 cases were effect ( 5 marked efficacy) ,4 inefficacy. Conclusion Herbal plus Westen medicine therapy is effective in the treatment of patients with lupus nephritis,and the project of low-dose prednisone plus azathioprine plus methotrexate plus Tripterggium Wilfordii is more efficient.
作者 许德清
出处 《中国皮肤性病学杂志》 CAS 北大核心 2005年第11期676-677,共2页 The Chinese Journal of Dermatovenereology
关键词 肾炙 狼疮 联合疗法 Lupus nephritis Union therapy
  • 相关文献

参考文献4

  • 1Hashimoto M, Nonaka S, Furuta E, et al. Methotrexate for steroid -resistant systemic lupus erythymatosus [ J ]. Clin Rheumatol, 1994,13:280- 283.
  • 2Rothenberg R J, Graziano FM, Grandote JT,et al. The use of methotrexate in steroid-resistant systemic lupus erythymatosus [ J ]. Arthritis Rheum,1988,31:612 -615.
  • 3蒋明 DavidYU 林孝义.系统性红斑狼疮的治疗[A]..见:中华风湿病学[M].北京:华厦出版社,2004.943.
  • 4林顺平,林淑屏,石艳清.甲氨蝶呤治疗系统性红斑狼疮临床研究[J].医师进修杂志,2004,27(6):32-33. 被引量:7

二级参考文献6

  • 1CRONSTEIN B N,NAIME D,OSTAD E.The antiinflammatory mechanism of methotrexate:increased adenosine release at inflamed sites diminishes leucocyte accumulation in an in vivo model of inflammation[J].J Clin Invest,1993,92:2 675.
  • 2TAN E M,COHEN A S,FRIES J F,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum,1982,25:1 271-1 277.
  • 3BOMBARDIER C,GLADMAN D D,UROWITZ M B,et al.A disease activity index for lupus patient:the committee on prognosis in SLE[J].Arthritis Rheum,1992,35:630-640.
  • 4CAMERON J S.Lupus nephritis[J].J Am Soc Nephrol, 1999,10:413.
  • 5CARNEIRO J R,SATO E I.Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus[J].J Rheumatol,1999,26:1 275-1 279.
  • 6陈盛,陈顺乐,顾越英,鲍春德.系统性红斑狼疮患者18年随访[J].中华风湿病学杂志,2000,4(1):27-30. 被引量:57

共引文献6

同被引文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部